Inflammatory cytokines in allergy and rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 3, 2010, Pages 187-190

  Daines, Steven M ^a   Orlandi, Richard R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy; Cytokines; Rhinosinusitis

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPY; DISEASE PREDISPOSITION; DRUG TARGETING; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; MEDICAL LITERATURE; MUCOSA INFLAMMATION; NOSE; NOSE POLYP; PARANASAL SINUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHINOSINUSITIS; TH1 CELL; TH2 CELL; COMPLICATION; IMMUNOLOGY; RHINITIS; SINUSITIS;

CYTOKINES; HUMANS; RHINITIS; SINUSITIS;

EID: 77952337808     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328338206a     Document Type: Review

References (38)

1. Cousins DJ, McDonald J, Lee TH. Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol 2008;121:803-809.
2. Scavuzzo MC, Rocchi V, Fattori B, et al. Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed Pharmacother 2003;57:366-371.
3. Riechelmann H, Deutschle T, Friemel E, et al. Biological markers in nasal secretions. Eur Respir J 2003;21:600-605.
4. Ramanathan M, Lane AP. Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2007;136:348-356.
5. Riechelmann H, Deutschle T, Rozsasi A, et al. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005;35:1186-1191.
6. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:1280-1289.
7. Gevaert P, Bachert C, Holtappels G, et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003;58:371-379.
8. Broide DH. Immunomodulation of allergic disease. Annu Rev Med 2009; • 60:279-291. A good summary of the potential role for anti-IL-5 in allergic diseases.
9. Simon HU, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-3908.
10. Perez-Novo CA, Watelet JB, Claeys C, et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-1196.
11. Rudack C, Sachse F, Alberty J. Chronic rhinosinusitis: need for further classification? Inflamm Res 2004;53:111-117.
12. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. Allergy Clin Immunol 2001;107:607-614.
13. Bachert C, Wagenmann M, Hauser U, et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842.
14. Hamilos DL, Leung DY, Huston DP, et al. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998;28:1145-1152.
15. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279-290.
16. Rinia AB, Kostamo K, Ebbens FA, et al. Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007;62:348-358.
17. Tachdjian R, Mathias C, Khatib S, et al. Pathogenicity of a disease-associated • human IL-4 receptor allele in experimental asthma. J Exp Med 2009;206:2191-2204. This study describes the mechanism by which a specific polymorphism in the IL-4Ra chain promotes asthma in a murine model.
18. Elias JA, Zhu Z, Chupp G, et al. Airway remodeling in asthma. J Clin Invest 1999;104:1001-1006.
19. Schmidt-Weber CB, Akdis M, Akdis CA. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 2007;120:247-254.
20. Benson M, Strannegard IL, Strannegard O, et al. Topical steroid treatment of allergic rhinitis decreases nasal fluid Th2 cytokines, eosinophils, eosinophil cationic protein and IgE but has no significant effect on IFN-λ, IL-1 β, TNF-α, or neutrophils. J Allergy Clin Immunol 2000;106:307-312.
21. Benson M, Strannegard IL, Wennergren G, et al. Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from scholar children with allergic rhinitis. Allergy Asthma Proc 2000;21:89-95.
22. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
23. Black S, Teixeira AS, Loh AXW, et al. Contribution of functional variation in the •• IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy 2009;64:1172-1178. This study demonstrates the role of two IL-13 SNPs in determining susceptibility to atopy and asthma. In a longitudinal cohort study of 2918 adults in the UK, variations in the IL-13 gene were correlated with self-reported asthma and allergy. This is one of the most recent studies that show the role of genetic polymorphisms in cytokines and their receptors in allergic diseases.
24. al GhamdiF K. Ghaffar O, Small P, et al. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997;26:160-166.
25. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202:175-190. (Pubitemid 39576912)
26. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998;102:165-169.
27. Zhu Z, Homer RJ, Wang Z. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
28. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005;115:684-686.
29. Ghaffar O, Lavigne F, Kamil A, et al. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 1998;118:504-511.
30. Damm M, Quante G, Rosenbohm J, et al. Proinflammatory effects of Staphylococcus aureus exotoxin B on nasal epithelial cells. Otolaryngol Head Neck Surg 2006;134:245-249.
31. Abdi K. IL-2: the role of p40 versus p75. Scand J Immunol 2002;56:1-11.
32. Randolph AG, Lange C, Silverman EK, et al. The IL12B gene is associated with asthma. Am J Hum Genet 2004;75:709-715.
33. Salib RJ, Howarth PH. Transforming growth factor-β in allergic inflammatory disease of the upper airway: friend or foe? Clin Exp Allergy 2009;39:1128-1135.
34. Salib RJ, Kumar S, Wilson SJ, et al. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxin, and stem cell factor and their receptors in allergic rhinitis. J Allergy Clin Immunol 2004;114:799-806.
35. Benson M, Carlsson B, Carlsson LM, et al. DNA microarray analysis of transforming growth factor-beta and related transcripts in nasal biopsies from patients with allergic rhinitis. Cytokine 2002;18:20-25.
36. Lee SS, Won TB, Kim JW, et al. Effects of dexamethasone on the expression of transforming growth factor-beta in the mouse model of allergic rhinitis. Laryngoscope 2007;117:1323-1328.
37. Border W, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
38. Wallwork B, Coman W, Mackay-Sim A, et al. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 2004;114:286-290.